Covid-19: Sweden and the United States - A discussion of covid-19 management, science and vaccine development.

PARTICIPANTS:
Mikael Dolsten, M.D., Ph.D. Chief Scientific Officer and President, Worldwide Research, Development and Medical of Pfizer Inc
Jonas F. Ludvigsson, Pediatrician, Universitetssjukhuset Örebro, Sweden and Professor of Clinical Epidemiology, Karolinska Institutet.
 
PROGRAMME:
In a conversation, Jonas F. Ludvigsson and Mikael Dolsten start off from Dolsten’s early life and career in Sweden, moving on to the international pharmaceutical industry, vaccine work and how Pfizer and Dr. Dolsten suddenly was in the limelight at the 2020 covid-19 pandemic.
The two will touch upon Sweden, the United States and covid-19 management by compareing the covid-19 strategy in Sweden and the United States, based on Ludvigsson’s paper (ref #1).
They will also discuss science, vaccine development and how Dolsten believes that the covid-19 situation will develop during 2021.
 
Ludvigsson, JF. The first eight months of Sweden’s COVID-19 strategy and the key actions and actors that were involved. Acta Paediatr. 2020 Dec;109(12):2459-2471.  
https://pubmed.ncbi.nlm.nih.gov/32951258/
 

På sls.se använder vi cookies för att din upplevelse ska bli så bra som möjligt. Genom att fortsätta använda vår webbplats accepterar du att cookies används.